文献速递肿瘤 PET/CT

68Ga-FAPI-46与18F-FDG在晚期转移性胰腺癌中的显像

68 Ga-FAPI-46 and 18 F-FDG in Advanced Metastatic Pancreatic Cancer.
PubMed 文献 · Clin Nucl Med · 2022-06-18

本文报告一例晚期胰腺腺癌患者,同时接受18F-FDG与68Ga-FAPI-46 PET/CT显像。结果显示68Ga-FAPI-46在转移灶及局部恶性复发病灶的检出方面显著改善,且病灶的显像强度与SUV值均高于18F-FDG。

要点

  • 68Ga-FAPI-46 PET/CT在晚期胰腺腺癌转移灶检出方面较18F-FDG显著改善。
  • 68Ga-FAPI-46对局部恶性复发病灶的检出亦优于18F-FDG。
  • 68Ga-FAPI-46显像中病灶的显像强度与SUV值均高于18F-FDG。

核心结论

  • 68Ga-FAPI-46显像在转移灶检出及局部恶性复发病灶检出方面较18F-FDG显著改善,且病灶显像强度与SUV值更高。

研究设计与样本

  • 个案报告:一例晚期胰腺腺癌患者,分别接受18F-FDG与68Ga-FAPI-46 PET/CT显像。

主要发现

  • 68Ga-FAPI-46显像在转移灶检出方面较18F-FDG显著改善。
  • 68Ga-FAPI-46显像在局部恶性复发病灶检出方面较18F-FDG显著改善。
  • 68Ga-FAPI-46显像中病灶的显像强度与SUV值均高于18F-FDG。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recently imaging with new PET radiotracers that act as fibroblast activation protein inhibitors (FAPIs) showed promising results in oncology and even nononcology imaging. Here we report a case of advanced pancreatic adenocarcinoma, imaged with both 18 F-FDG and 68 Ga-FAPI-46 PET/CT scans. The result indicated that imaging with 68 Ga-FAPI-46 showed significant improvement in detection of metastases as well as local malignancy recurrence. Moreover, the intensity and SUVs of the lesions were higher in 68 Ga-FAPI-46 scan compared with 18 F-FDG.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kaghazchi F, Divband G, Amini H, et al. 68 Ga-FAPI-46 and 18 F-FDG in Advanced Metastatic Pancreatic Cancer. Clin Nucl Med. 2022. PMID: 35714370. doi:10.1097/RLU.0000000000004316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。